Heather Thibeau

Heather Thibeau

Auto-generated profile, based on publicly available information

Heather Thibeau

Icahn School of Medicine at Mount Sinai

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2026 in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Verified
Journal Article
Open access
SHShalaila S. Haas
Shalaila S. Haas
RJRachel Jespersen
Rachel Jespersen
JCJoseph T. Colonel
Joseph T. Colonel
ADAdam Davidson
Adam Davidson
BTBailey M. Todtfeld
Bailey M. Todtfeld
RKRené S. Kahn
René S. Kahn

9 September 2026 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
RCRenata Gonzalez Chong
Renata Gonzalez Chong
DODeborah Obiajulu
Deborah Obiajulu
HTHeather Thibeau
Heather Thibeau
SSSafrana Safa
Safrana Safa
MGMackenzie Glanville
Mackenzie Glanville
NSNicole W. Simons
Nicole W. Simons
Background: Artificial intelligence (AI) is explored as a tool to expand access to mental health care, offering support and self-disclosure. To date, the perspectives of individuals with schizophrenia on AI have been absent from the medical literature. This exploratory study represents an effort to report schizophrenia patient perspectives on AI chatbots through a focus group. Methods: We conducted an exploratory, cross-sectional, qualitative study using semi-structured focus groups at a large academic health center in New York City. Participants included patients with schizophrenia spectrum disorders ( n = 17), caregivers ( n = 7), and providers ( n = 4). Discussions explored familiarity with AI, privacy, and perceived utility of a hypothetical AI companion tool. Transcripts were analyzed using thematic analysis. Results: Five themes were identified in this exploratory analysis: (1) ‘Available When No One Else Is’, reflecting participants’ recognition of AI as a potentially accessible source of between-visit support; (2) ‘What Would It Do?’ capturing uncertainty about AI’s role; (3) ‘How Can I Trust It?’ highlighting trust as the central barrier, shaped by privacy concerns and schizophrenia-specific vulnerabilities; (4) ‘A Tool, Not a Therapist’, emphasizing that AI was acceptable only as a supplement to, not a replacement for, human care; and (5) ‘Keep It Low-Risk’, describing the narrow range of acceptable use cases, limited to supportive functions. Conclusions: These exploratory findings suggest that AI is perceived as both a promising adjunct to care and a potential risk in schizophrenia. Implementation should emphasize transparency, trust, and clear boundaries, with AI designed to support, not replace, existing care.